SKIN - These Analysts Increase Their Forecasts On Beauty Health Following Strong Sales | Benzinga
The Beauty Health Company (NASDAQ: SKIN) reported better-than-expected fourth-quarter revenue results on Tuesday.
Beauty Health posted quarterly loss of 7 cents per share, in-line with market estimates. The company’s quarterly sales came in at $96.80 million versus expectations of $87.63 million, according to data from Benzinga Pro, according to data from Benzinga Pro.
Gross margin narrowed to 47.2% in the fourth quarter from 67.8% in the year-ago period. Adjusted gross margin shrank to 54.6% from 73.6%.
"To close 2023, we delivered fourth quarter financial results consistent with the expectations we outlined on our last earnings ...